Unicycive Therapeutics Ownership | Who Owns Unicycive Therapeutics?

Unicycive Therapeutics Ownership Summary

Unicycive Therapeutics is owned by 52.60% institutional investors, 6.73% insiders, and 40.66% retail investors. Vivo capital is the largest institutional shareholder, holding 9.94% of UNCY shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 0.81% of its assets in Unicycive Therapeutics shares.

UNCY Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Unicycive Therapeutics	52.60%	6.73%	40.66%
Sector	Healthcare Stocks	49.73%	8.84%	41.43%
Industry	Biotech Stocks	47.04%	8.74%	44.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Vivo capital	3.47M	9.94%	$1.74M
Logos global management lp	3.47M	9.94%	$1.74M
Nantahala capital management	2.82M	8.08%	$1.41M
Vanguard group	1.14M	3.26%	$570.36K
Geode capital management	285.74K	0.82%	$143.18K
Goldman sachs group	93.35K	0.27%	$46.78K
Lpl financial	85.00K	0.24%	$42.59K
Blackrock	51.84K	0.15%	$25.98K
State street	43.94K	0.13%	$22.02K
Northern trust	24.00K	0.07%	$12.03K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Vivo capital	3.47M	0.16%	$1.74M
Logos global management lp	3.47M	0.14%	$1.74M
Nantahala capital management	2.82M	0.08%	$1.41M
Tandem capital management corp /adv	15.50K	0.00%	$7.08K
Virtu financial	11.09K	0.00%	$6.00K
Tower research capital llc (trc)	18.48K	0.00%	$9.26K
Monashee investment management	-	-	-
Bvf inc/il	-	-	-
Renaissance	-	-	-
Northern trust	24.00K	-	$12.03K

Top Buyers

Holder	Shares	% Assets	Change
Vanguard group	1.14M	-	798.36K
Lpl financial	85.00K	-	85.00K
Blackrock	51.84K	-	51.84K
Geode capital management	285.74K	-	32.55K
Tower research capital llc (trc)	18.48K	0.00%	10.81K

Top Sellers

Holder	Shares	% Assets	Change
Ra capital management	-	-	-2.63M
Bvf inc/il	-	-	-2.20M
Rosalind advisors	-	-	-1.57M
Monashee investment management	-	-	-1.00M
Nantahala capital management	2.82M	0.08%	-515.23K

New Positions

Holder	Shares	% Assets	Change	Value
Lpl financial	85.00K	-	85.00K	$42.59K
Blackrock	51.84K	-	51.84K	$25.98K
Bank of america corp /de/	223.00	-	223.00	$112.00

Sold Out

Holder	Change
Wells fargo & company/mn	-196.00
Redwood wealth management group	-3.00K
Integrated wealth concepts	-10.00K
Scientech research	-10.97K
Ground swell capital	-19.12K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2024	28	16.67%	46,786,564	146.28%	52	1.78%	22	100.00%	-	-100.00%
Jun 30, 2024	24	4.35%	18,997,260	-10.59%	54	0.73%	11	-26.67%	7	250.00%
Mar 31, 2024	23	43.75%	21,247,089	63.05%	86	5.43%	15	114.29%	2	-33.33%
Dec 31, 2023	16	-	13,030,671	-8.19%	39	0.46%	7	-12.50%	3	-25.00%
Sep 30, 2023	16	6.67%	14,192,814	1220.89%	93	187.23%	8	14.29%	4	100.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	765.00K	0.81%	-
Vanguard Institutional Extnd Mkt Idx Tr	373.22K	0.38%	-
Fidelity Extended Market Index	234.56K	0.25%	85.08K
iShares Micro-Cap ETF	65.37K	0.07%	-
Fidelity Series Total Market Index	54.03K	0.06%	26.32K
Fidelity Total Market Index	42.77K	0.05%	-
Fidelity Nasdaq Composite Index	26.11K	0.03%	-
Spartan Extended Market Index Pool E	26.07K	0.03%	26.07K
Northern Trust Extended Eq Market Idx	22.40K	0.02%	-
NT Ext Equity Mkt Idx Fd - L	22.40K	0.02%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
May 16, 2022	Schiller Brigitte		Buy	$12.38K

Insider Transactions Trends

Date	Buy	Sell
2024 Q4	-	-
2024 Q3	-	-
2024 Q2	-	-
2023 Q3	-	-
2023 Q1	-	-

UNCY Ownership FAQ

Who Owns Unicycive Therapeutics?

Unicycive Therapeutics shareholders are primarily institutional investors at 52.60%, followed by 6.73% insiders and 40.67% retail investors. The average institutional ownership in Unicycive Therapeutics's industry, Biotech Stocks , is 47.04%, which Unicycive Therapeutics exceeds.

Who owns the most shares of Unicycive Therapeutics?

Unicycive Therapeutics’s largest shareholders are Vivo capital (3.47M shares, 9.94%), Logos global management lp (3.47M shares, 9.94%), and Nantahala capital management (2.82M shares, 8.08%). Together, they hold 27.96% of Unicycive Therapeutics’s total shares outstanding.

Does Blackrock own Unicycive Therapeutics?

Yes, BlackRock owns 0.15% of Unicycive Therapeutics, totaling 51.84K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 25.98K$. In the last quarter, BlackRock increased its holdings by 51.84K shares, a 100.00% change.

Who is Unicycive Therapeutics’s biggest shareholder by percentage of total assets invested?

Vivo capital is Unicycive Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.16% of its assets in 3.47M Unicycive Therapeutics shares, valued at 1.74M$.

Who is the top mutual fund holder of Unicycive Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Unicycive Therapeutics shares, with 0.81% of its total shares outstanding invested in 765K Unicycive Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools